Literature DB >> 16536480

A novel ternary ligand system useful for preparation of cationic (99m)Tc-diazenido complexes and (99m)Tc-labeling of small biomolecules.

Young-Seung Kim1, Zhengjie He, Wen-Yuan Hsieh, Shuang Liu.   

Abstract

This report describes a novel ternary ligand system composed of a phenylhydrazine, a crown ether-containing dithiocarbamate (DTC), and a PNP-type bisphosphine (PNP). The combination of three different ligands with (99m)Tc results in cationic (99m)Tc-diazenido complexes, [(99m)Tc(NNAr)(DTC)(PNP)]+, with potential radiopharmaceuticals for heart imaging. Synthesis of cationic (99m)Tc-diazenido complexes can be accomplished in two steps. For example, the reaction of phenylhydrazine with (99m)TcO4- at 100 degrees C in the presence of excess stannous chloride and 1,2-diaminopropane-N,N,N',N'-tetraacetic acid (PDTA) results in the [(99m)Tc(NNPh)(PDTA)n] intermediate, which then reacts with sodium N-(dithiocarbamato)-2-aminomethyl-15-Crown-5 (L4) and N,N-bis[2-(bis(3-ethoxypropyl)phosphino)ethyl]ethoxyethylamine (PNP6) at 100 degrees C for 15 min to give the complex, [(99m)Tc(NNPh)(L4)(PNP6)]+ in high yield (>90%). Cationic complexes [(99m)Tc(NNPh)(DTC)(PNP)]+ are stable for > or = 6 h. Their composition was determined to be 1:1:1:1 for Tc:NNPh:DTC:PNP using the mixed-ligand experiments on the tracer ((99m)Tc) level and was further confirmed by the ESI-MS spectral data of a model compound [Re(NNPh)(L4)(L6)]+. It was found that both DTCs and bisphosphines have a significant impact on the lipophilicity of their cationic (99m)Tc-diazenido complexes. Results from a (99m)Tc-labeling efficiency experiment showed that 4-hydrazinobenzoic acid (HYBA) might be useful as a bifunctional coupling agent for (99m)Tc-labeling of small biomolecules. However, the (99m)Tc-labeling efficiency of HYBA is much lower than that of 6-hydrazinonicotinic acid (HYNIC) with tricine and trisodium triphenylphosphine-3,3',3''-trisulfonate (TPPTS) as coligands.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16536480      PMCID: PMC2597566          DOI: 10.1021/bc0502715

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  49 in total

1.  Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.

Authors:  C Decristoforo; S J Mather
Journal:  Eur J Nucl Med       Date:  1999-08

2.  Preparation and characterization of technetium complexes with Schiff base and phosphine coordination. 1. Complexes of technetium-99g and -99m with substituted acac2en and trialkyl phosphines (where acac2en = N,N'-ethylenebis[acetylacetone iminato]).

Authors:  M E Marmion; S R Woulfe; W L Neumann; D L Nosco; E Deutsch
Journal:  Nucl Med Biol       Date:  1999-10       Impact factor: 2.408

3.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

4.  New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds.

Authors:  Marina Porchia; Francesco Tisato; Fiorenzo Refosco; Cristina Bolzati; Mario Cavazza-Ceccato; Giuliano Bandoli; Alessandro Dolmella
Journal:  Inorg Chem       Date:  2005-06-27       Impact factor: 5.165

5.  Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection.

Authors:  J W Babich; H Solomon; M C Pike; D Kroon; W Graham; M J Abrams; R G Tompkins; R H Rubin; A J Fischman
Journal:  J Nucl Med       Date:  1993-11       Impact factor: 10.057

6.  Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.

Authors:  P A Carvalho; M L Chiu; J F Kronauge; M Kawamura; A G Jones; B L Holman; D Piwnica-Worms
Journal:  J Nucl Med       Date:  1992-08       Impact factor: 10.057

7.  New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.

Authors:  D S Edwards; S Liu; J A Barrett; A R Harris; R J Looby; M C Ziegler; S J Heminway; T R Carroll
Journal:  Bioconjug Chem       Date:  1997 Mar-Apr       Impact factor: 4.774

8.  99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.

Authors:  C Decristoforo; S J Mather; W Cholewinski; E Donnemiller; G Riccabona; R Moncayo
Journal:  Eur J Nucl Med       Date:  2000-09

9.  A class of asymmetrical nitrido 99mTc heterocomplexes as heart imaging agents with improved biological properties.

Authors:  A Boschi; C Bolzati; L Uccelli; A Duatti; E Benini; F Refosco; F Tisato; A Piffanelli
Journal:  Nucl Med Commun       Date:  2002-07       Impact factor: 1.690

10.  Cationic [99mTcIII(DIARS)2(SR)2]+ complexes as potential myocardial perfusion imaging agents (DIARS = o-phenylenebis(dimethylarsine);SR- = thiolate).

Authors:  F Tisato; T Maina; L R Shao; M J Heeg; E Deutsch
Journal:  J Med Chem       Date:  1996-03-15       Impact factor: 7.446

View more
  8 in total

1.  Evaluation of (99)  (m)TcN-MPO as a new myocardial perfusion imaging agent in normal dogs and in an acute myocardial infarction canine model: comparison with (99)  (m)Tc-sestamibi.

Authors:  Lihong Bu; Renfei Li; Zhongnan Jin; Xiaofei Wen; Shuang Liu; Baofeng Yang; Baozhong Shen; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

2.  Novel 99mTc(III)-azide complexes [99mTc(N3)(CDO)(CDOH)2B-R] (CDOH2=cyclohexanedione dioxime) as potential radiotracers for heart imaging.

Authors:  Min Liu; Yumin Zheng; Ugur Avcibasi; Shuang Liu
Journal:  Nucl Med Biol       Date:  2016-05-09       Impact factor: 2.408

3.  (99m)Tc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study.

Authors:  Cristina Bolzati; Davide Carta; Valentina Gandin; Cristina Marzano; Nicolò Morellato; Nicola Salvarese; Mariangela Cantore; Nicola Antonio Colabufo
Journal:  J Biol Inorg Chem       Date:  2013-03-31       Impact factor: 3.358

Review 4.  Dithiocarbamate complexes as radiopharmaceuticals for medical imaging.

Authors:  David J Berry; Rafael Torres Martin de Rosales; Putthiporn Charoenphun; Philip J Blower
Journal:  Mini Rev Med Chem       Date:  2012-10       Impact factor: 3.862

5.  Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.

Authors:  Valerie Carroll; Dustin W Demoin; Timothy J Hoffman; Silvia S Jurisson
Journal:  Radiochim Acta       Date:  2012-08       Impact factor: 1.440

6.  N-Centered Tripodal Phosphine Re(V) and Tc(V) Oxo Complexes: Revisiting a [3 + 2] Mixed-Ligand Approach.

Authors:  Saul M Cooper; Andrew J P White; Thomas R Eykyn; Michelle T Ma; Philip W Miller; Nicholas J Long
Journal:  Inorg Chem       Date:  2022-05-11       Impact factor: 5.436

7.  Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging.

Authors:  Young-Seung Kim; Jianjun Wang; Alexis Broisat; David K Glover; Shuang Liu
Journal:  J Nucl Cardiol       Date:  2008-04-21       Impact factor: 5.952

8.  Mechanism for myocardial localization and rapid liver clearance of Tc-99m-N-MPO: a new perfusion radiotracer for heart imaging.

Authors:  Young-Seung Kim; Jiyun Shi; Shizhen Zhai; Guihua Hou; Shuang Liu
Journal:  J Nucl Cardiol       Date:  2009-03-14       Impact factor: 5.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.